126 related articles for article (PubMed ID: 10431111)
1. Decreased trabecular bone mineral density in children with idiopathic short stature: normalization of bone density and increased bone turnover after 1 year of growth hormone treatment.
Lanes R; Gunczler P; Weisinger JR
J Pediatr; 1999 Aug; 135(2 Pt 1):177-81. PubMed ID: 10431111
[TBL] [Abstract][Full Text] [Related]
2. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study.
Lanes R; Gunczler P; Esaa S; Weisinger JR
Clin Endocrinol (Oxf); 2002 Dec; 57(6):725-30. PubMed ID: 12460321
[TBL] [Abstract][Full Text] [Related]
3. Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.
Lanes R
Curr Pharm Biotechnol; 2000 Jul; 1(1):33-46. PubMed ID: 11467359
[TBL] [Abstract][Full Text] [Related]
4. Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major.
Sartorio A; Conte G; Conti A; Masala A; Alagna S; Rovasio P; Faglia G
J Endocrinol Invest; 2000 Jun; 23(6):356-61. PubMed ID: 10908162
[TBL] [Abstract][Full Text] [Related]
5. Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults.
Välimäki MJ; Salmela PI; Salmi J; Viikari J; Kataja M; Turunen H; Soppi E
Eur J Endocrinol; 1999 Jun; 140(6):545-54. PubMed ID: 10377504
[TBL] [Abstract][Full Text] [Related]
6. Responses of bone turnover markers and bone mineral density to growth hormone therapy in children with isolated growth hormone deficiency and multiple pituitary hormone deficiencies.
Kandemir N; Gonc EN; Yordam N
J Pediatr Endocrinol Metab; 2002 Jun; 15(6):809-16. PubMed ID: 12099391
[TBL] [Abstract][Full Text] [Related]
7. Impact of the growth hormone replacement on bone status in growth hormone deficient adults.
Kužma M; Kužmová Z; Zelinková Z; Killinger Z; Vaňuga P; Lazurová I; Tomková S; Payer J
Growth Horm IGF Res; 2014 Feb; 24(1):22-8. PubMed ID: 24382377
[TBL] [Abstract][Full Text] [Related]
8. Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents.
Fors H; Bjarnason R; Wirént L; Albertsson-Wikland K; Bosaeust L; Bengtsson BA; Johannsson G
Clin Endocrinol (Oxf); 2001 Nov; 55(5):617-24. PubMed ID: 11894973
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
Gonc EN; Kandemir N
Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density, bone metabolism and body composition of children with chronic renal failure, with and without growth hormone treatment.
Boot AM; Nauta J; de Jong MC; Groothoff JW; Lilien MR; van Wijk JA; Kist-van Holthe JE; Hokken-Koelega AC; Pols HA; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 1998 Nov; 49(5):665-72. PubMed ID: 10197084
[TBL] [Abstract][Full Text] [Related]
11. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass.
Saggese G; Baroncelli GI; Bertelloni S; Barsanti S
J Clin Endocrinol Metab; 1996 Aug; 81(8):3077-83. PubMed ID: 8768878
[TBL] [Abstract][Full Text] [Related]
12. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency.
Johannsson G; Rosén T; Bosaeus I; Sjöström L; Bengtsson BA
J Clin Endocrinol Metab; 1996 Aug; 81(8):2865-73. PubMed ID: 8768843
[TBL] [Abstract][Full Text] [Related]
13. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
14. Bone alkaline phosphatase and collagen markers as early predictors of height velocity response to growth-promoting treatments in short normal children.
Crofton PM; Stirling HF; Schönau E; Kelnar CJ
Clin Endocrinol (Oxf); 1996 Apr; 44(4):385-94. PubMed ID: 8706304
[TBL] [Abstract][Full Text] [Related]
15. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
Colao A; Di Somma C; Pivonello R; Loche S; Aimaretti G; Cerbone G; Faggiano A; Corneli G; Ghigo E; Lombardi G
J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
[TBL] [Abstract][Full Text] [Related]
16. Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus.
Gunczler P; Lanes R; Paoli M; Martinis R; Villaroel O; Weisinger JR
J Pediatr Endocrinol Metab; 2001 May; 14(5):525-8. PubMed ID: 11393573
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults.
Kann P; Piepkorn B; Schehler B; Andreas J; Lotz J; Prellwitz W; Beyer J
Clin Endocrinol (Oxf); 1998 May; 48(5):561-8. PubMed ID: 9666867
[TBL] [Abstract][Full Text] [Related]
19. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
Longobardi S; Di Rella F; Pivonello R; Di Somma C; Klain M; Maurelli L; Scarpa R; Colao A; Merola B; Lombardi G
J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
[TBL] [Abstract][Full Text] [Related]
20. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]